治疗用药豁免(Therapeutic Use Exemption,TUE)规则属于世界反兴奋剂机制下的5项国际标准之一。TUE的申请涉及当运动员因服用治疗性药物导致兴奋剂检测结果呈阳性时,是否能够免除处罚的问题。该规则的产生源于实践案例:人们意识到,只要...治疗用药豁免(Therapeutic Use Exemption,TUE)规则属于世界反兴奋剂机制下的5项国际标准之一。TUE的申请涉及当运动员因服用治疗性药物导致兴奋剂检测结果呈阳性时,是否能够免除处罚的问题。该规则的产生源于实践案例:人们意识到,只要存在违禁物质就处罚运动员是苛刻的,某些疾病的用药必然导致兴奋剂物质存于运动员体内,但并无益于提高运动员赛事能力。通过对CAS(体育仲裁院)公开的首次涉及治疗用药豁免规则案例的叙述,分析其产生的理论逻辑,在肯定其提出的意义之后,对其实质性内容进行批判,以期得到进一步完善。展开更多
Androgenic-anabolic steroids （AAS） have been misused by athletes at the Olympic Games, both before and after they were prohibited in sport in 1974. Systematic doping with AAS occurred in the German Democratic Republ...Androgenic-anabolic steroids （AAS） have been misused by athletes at the Olympic Games, both before and after they were prohibited in sport in 1974. Systematic doping with AAS occurred in the German Democratic Republic （GDR） from 1965 to 1989 which assisted that country to win many medals at Olympic Games, especially in female events. Currently, AAS are the most frequent category of prohibited substances detected in the urine of athletes both globally and at the last two Summer Olympic Games. Scientific confirmation that AAS are effective in enhancing sports performance was difficult because ethical approval was difficult for research involving male subjects taking massive doses of androgens as some athletes and bodybuilders did. Methods to detect AAS have evolved gradually over the past three decades and currently, despite an impressive array of sophisticated analytical equipment and methods, anti-doping authorities and analytical scientists continue to face challenges as have occurred from the use by athletes of designer AAS during the past few years. The future development and use of selective androgen receptor modulators （SARMs） can be anticipated to pose problems in the years ahead. Endocrinologists should be aware that on occasions, replacement testosterone （T） therapy may be authorized in sport as a therapeutic use exemption （TUE） and these circumstances are discussed.展开更多
文摘治疗用药豁免(Therapeutic Use Exemption,TUE)规则属于世界反兴奋剂机制下的5项国际标准之一。TUE的申请涉及当运动员因服用治疗性药物导致兴奋剂检测结果呈阳性时,是否能够免除处罚的问题。该规则的产生源于实践案例:人们意识到,只要存在违禁物质就处罚运动员是苛刻的,某些疾病的用药必然导致兴奋剂物质存于运动员体内,但并无益于提高运动员赛事能力。通过对CAS(体育仲裁院)公开的首次涉及治疗用药豁免规则案例的叙述,分析其产生的理论逻辑,在肯定其提出的意义之后,对其实质性内容进行批判,以期得到进一步完善。
文摘Androgenic-anabolic steroids （AAS） have been misused by athletes at the Olympic Games, both before and after they were prohibited in sport in 1974. Systematic doping with AAS occurred in the German Democratic Republic （GDR） from 1965 to 1989 which assisted that country to win many medals at Olympic Games, especially in female events. Currently, AAS are the most frequent category of prohibited substances detected in the urine of athletes both globally and at the last two Summer Olympic Games. Scientific confirmation that AAS are effective in enhancing sports performance was difficult because ethical approval was difficult for research involving male subjects taking massive doses of androgens as some athletes and bodybuilders did. Methods to detect AAS have evolved gradually over the past three decades and currently, despite an impressive array of sophisticated analytical equipment and methods, anti-doping authorities and analytical scientists continue to face challenges as have occurred from the use by athletes of designer AAS during the past few years. The future development and use of selective androgen receptor modulators （SARMs） can be anticipated to pose problems in the years ahead. Endocrinologists should be aware that on occasions, replacement testosterone （T） therapy may be authorized in sport as a therapeutic use exemption （TUE） and these circumstances are discussed.
